| Title | Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases |
|---|---|
| Disease/Condition | Brain Cancer,Metastatic Cancer |
| Eligibility Criteria | Ages Eligible for Study: 18 Years and older Genders Eligible for Study: Both Accepts Healthy Volunteers: No Click here for eligibility requirements |
| Principal Investigator | William Bodner, MD |
| Contact Name | Alyssa Asaro |
| Phone | (718) 920-7750 |
| Contact Email | aasaro@montefiore.org |
| IRB/Protocol Number | IRB# 2015-5530 |
| Status | Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |